Last week, the Federal Trade Commission (“FTC”) fired a warning shot across the bow of PBMs, but Manufacturers and Plan Sponsors must also take note. On June 16, 2022, the FTC announced that it will “ramp up enforcement against any illegal... Read More
Frier Levitt's Plan Sponsor Co-Chairs Jonathan Levitt, Esq., and Dae Lee, Pharm.D., Esq., CPBS, Author Article for BenefitsPRO on Plan sponsors losing manufacturer rebate dollars to PBMs through rebate aggregators. Pharmacy benefit managers... Read More
As we have reported in prior manufacturer rebate articles, Pharmacy Benefit Managers (“PBMs”) have created opaque manufacturer rebate arrangements, either directly or through wholly owned subsidiaries. These subsidiaries are “Rebate... Read More
Frier Levitt recently obtained a $6.25 Million settlement against a Pharmacy Benefits Manager(“PBM”) on behalf of its Plan Sponsor client (“Plan”). The Plan contracted with the PBM to administer its prescription drug program, and to... Read More
On November 20, 2020, the Trump administration announced plans to scrap the Medicare Part D “rebate safe harbor,” which currently permits insurance middlemen called Pharmacy Benefits Managers (“PBMs”) to charge manufacturers substantial fees... Read More
Contracting with Pharmacy Benefit Managers (“PBMs”) is a daunting task and one that Plan Sponsors should not delegate and entrust to non-fiduciary brokers or consultants. Some benefit brokers put their personal interests above their clients and... Read More
https://youtu.be/8mubYuuHvMI Frier Levitt co-founder Jonathan Levitt, Esq. and pharmacist attorney Dae Lee, Pharm.D., Esq., CPBS talk about rebates and PBMs. Unfortunately, Plan Sponsors often get taken advantage of by PBMs with manufacturers. It... Read More
Plan Sponsors should be aware of a few recent developments that lead to high gross and net drug prices. First, the White House recently withdrew a Notice of Proposed Rule Making (NPRM) that would have altered the entire drug marketplace. The NPRM... Read More
